poisar

Stocks · News reference

Oklo's New Reactor Milestone Lowers the Risk in Its Path to Approval

BenzingaAug 10, 2026, 4:06 PMPriya Nigam

OKLO shares dropped after Q2 results showed higher expenses. Analyst Sameer Joshi maintains Buy rating with $90 target.

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Aug 10, 2026, 4:06 PM
Checked
Aug 10, 2026, 4:06 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Zacks Investment ResearchAug 27, 2026, 4:22 PMNa

    CCJ's Uranium Production Down 5% in 1H26: Will 2026 Targets be Met?

    Cameco Corporation reported a 5% decline in H1 2026 uranium production to 10.1 million pounds, with mixed performance across operations. McArthur River/Key Lake production rose 14% to 5.8 million pounds, but Cigar Lake output fell to 4.3 million pounds due to maintenance outages and operational challenges. Despite disruptions including flooding in Saskatchewan and equipment issues, Cameco maintained its 2026 production guidance at 19.5-21.5 million pounds. Energy Fuels made solid progress with 1.7 million pounds of finished uranium in H1, tracking toward its 2026 target of 1.5-2.5 million pounds.

    Read original at zacks-investment-research
  2. The Motley FoolAug 23, 2026, 10:26 PMDaniel Sparks

    Prediction: Oklo Won't Book Its First Commercial Power Revenue Before 2028

    Oklo achieved its first nuclear criticality in August 2026 and reported initial revenue from services, but analyst Daniel Sparks predicts the company won't generate commercial power revenue until 2028 at the earliest. While the company demonstrated rapid construction capabilities with its test reactor, the first Aurora powerhouse at Idaho National Laboratory faces three remaining regulatory approval steps, fuel fabrication delays, and complex startup procedures. Oklo has sufficient cash reserves ($3 billion) to fund operations through 2028, with isotope revenue expected in early 2027 before commercial power sales begin.

    Read original at the-motley-fool
  3. The Motley FoolAug 27, 2026, 9:15 AMRyan Vanzo

    Even Elon Musk Now Admits Natural Gas Isn't Going Away. Here's What That Means for Nuclear Energy Stocks, Including NuScale Power and Oklo

    Elon Musk has reversed his stance on natural gas, acknowledging it will play a long-term role as a bridge fuel, particularly to support SpaceX's growing energy demands. This shift threatens the near-term growth prospects of small modular reactor (SMR) companies like NuScale Power and Oklo, as AI companies may opt for cheaper natural gas solutions instead of waiting for SMR deployment. The delay could stretch cash flow timelines and increase financial uncertainty for unprofitable SMR developers.

    Read original at the-motley-fool